CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

Home About CADTH What We Do Programs and Services Drug Reimbursement Review Canagliflozin

Canagliflozin

Last Updated: June 5, 2013

Result type: Reports

Project Number: SR0335

Product Line: Reimbursement Review

Generic Name: Canagliflozin

Brand Name: Invokana

Manufacturer: Janssen Inc.

Indications: Diabetes mellitus, type 2

Submission Type: Initial

Project Status: Withdrawn

Canagliflozin

Files